Definitive Healthcare Corp. DH
0.95
(0.06)
(5.94%)
as of 25 Sep
- Market cap
- $146.3M
- P/E
- 0.0×
Follow DH
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 45.94 | 45.94 | 15.12 | 5.09 | 4.55 | 1.90 | 1.27 |
P/FCF ratio |
— | 251.28 | 251.28 | 135.93 | 41.55 | 29.95 | 10.46 | 8.26 |
P/Operating CF |
— | 767.12 | 767.12 | 595.42 | (268.36) | 243.06 | 58.93 | 112.53 |
P/B ratio |
— | 5.50 | 5.50 | 1.67 | 0.76 | 0.95 | 0.79 | 0.81 |
Price to Tangible BV |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | 48.95 | 48.95 | 14.42 | 4.78 | 4.35 | 1.71 | 1.20 |
EV/EBITDA |
— | 0.00 | 0.00 | 61.23 | 47.59 | 47.48 | 9.43 | 6.55 |
EV/Operating CF |
— | 218.94 | 218.94 | 95.00 | 29.93 | 26.53 | 7.43 | 5.39 |
EV/FCF |
— | 267.71 | 267.71 | 129.61 | 39.08 | 28.60 | 9.43 | 7.83 |
Quick Ratio |
— | 0.48 | 0.65 | 3.50 | 2.78 | 2.15 | 2.13 | 1.49 |
Current Ratio |
— | 0.52 | 0.72 | 3.61 | 2.94 | 2.31 | 2.30 | 1.64 |
Net Debt/EBITDA |
— | 24.47 | 9.22 | (2.99) | (3.02) | (2.25) | (1.03) | (0.36) |
Debt/Assets |
0.00% | 25.53% | 26.46% | 12.78% | 12.45% | 14.04% | 22.32% | 22.41% |
Debt/Equity |
— | 0.36 | 0.39 | 0.18 | 0.18 | 0.21 | 0.40 | 0.43 |
Asset Turnover |
— | 0.10 | 0.07 | 0.09 | 0.11 | 0.13 | 0.17 | 0.26 |
Operating CF/Net income |
— | 0.00 | (0.45) | (1.41) | (4.93) | (0.20) | (0.14) | (0.39) |
Capex/Depreciation |
— | (0.05) | (0.02) | (0.10) | (0.13) | (0.01) | (0.02) | (0.06) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 0.00% | (4.24%) | (1.32%) | (0.48%) | (15.10%) | (45.74%) | (28.18%) | |
| — | 0.00% | (2.95%) | (0.92%) | (0.34%) | (10.25%) | (28.34%) | (15.23%) | |
ROIC |
— | (0.68%) | (0.61%) | (1.23%) | (1.95%) | (17.96%) | (79.31%) | (38.62%) |
Return on Tangible Assets |
— | 0.00% | 236.51% | (5.47%) | (2.60%) | (88.88%) | (194.14%) | (122.41%) |
Average Days of Receivables |
— | 106.81 | 102.14 | 95.20 | 96.39 | 86.02 | 77.04 | 78.55 |
Research and Development Expense of Revenue |
— | 8.71% | 9.35% | 11.17% | 15.67% | 16.88% | 14.48% | 14.40% |
Selling, General and Administrative Expense of Revenue |
— | 43.50% | 41.16% | 53.72% | 63.39% | 61.01% | 52.76% | 55.18% |
Intangible Assets out of Total Assets |
0.00 | 0.98 | 0.96 | 0.76 | 0.79 | 0.77 | 0.63 | 0.60 |
Share Based Compensation of Revenue |
— | 7.66% | 1.48% | 5.99% | 16.36% | 19.39% | 15.10% | 12.07% |
Graham Net Nets |
— | (0.08) | (0.08) | (0.07) | (0.20) | (0.20) | (0.23) | (0.32) |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (0.81%) | (0.81%) | (1.32%) | (0.63%) | (17.54%) | (85.64%) | (43.55%) |
Free Cash Flow Yield |
— | 0.40% | 0.40% | 0.74% | 2.41% | 3.34% | 9.56% | 12.11% |
Revenue per Share |
— | 0.57 | 1.22 | 1.81 | 2.20 | 2.23 | 2.16 | 2.26 |
Operating CF per Share |
— | 0.14 | 0.24 | 0.27 | 0.35 | 0.37 | 0.50 | 0.50 |
Capex per Share |
— | (0.01) | (0.01) | (0.07) | (0.08) | (0.03) | (0.11) | (0.16) |
Free Cash Flow per Share |
— | 0.13 | 0.22 | 0.20 | 0.27 | 0.34 | 0.39 | 0.35 |
Cash per Share |
— | 0.06 | 0.26 | 4.22 | 3.28 | 2.73 | 2.49 | 1.70 |
Shareholders Equity per Share |
— | 8.16 | 12.32 | 16.32 | 14.66 | 10.63 | 5.21 | 3.55 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 8.16 | 12.32 | 16.32 | 14.66 | 10.63 | 5.21 | 3.55 |
Free Cash Flow |
— | 19.69 | 21.82 | 18.48 | 27.25 | 38.21 | 45.85 | 37.06 |
Working Capital |
— | (33.81) | (24.88) | 321.11 | 273.14 | 223.25 | 209.01 | 100.82 |
Capital Expenditures |
— | (1.90) | (1.39) | (6.73) | (8.33) | (2.98) | (12.34) | (16.72) |
Net Current Asset Value |
— | (468.81) | (485.95) | (173.55) | (226.93) | (232.80) | (112.02) | (98.89) |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.02 | 0.01 | 0.04 | 0.04 | 0.01 | 0.05 | 0.07 |
Net Profit Margin |
— | 0.00% | (43.24%) | (10.74%) | (3.24%) | (80.50%) | (163.81%) | (57.52%) |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | 13.93 | 19.49 | 13.11 | 14.88 | 78.91 | 199.59 | 21.18 |
Cash ROIC |
— | 1.14% | 1.19% | 0.93% | 1.50% | 2.08% | 4.77% | 5.67% |
Accounts Receivable Turnover |
— | 2.95 | 4.07 | 4.35 | 4.36 | 4.26 | 4.48 | 4.59 |
Accounts Payable Turnover |
— | 4.65 | 7.79 | 7.89 | 9.91 | 9.75 | 6.61 | 8.11 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | 42.31 | 67.83 | 41.72 | 33.81 | 44.49 | 71.78 | 22.53 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | 29.00 | 29.06 | 38.22 | 51.07 | 59.02 | 56.24 | 52.61 |
Average Payables |
— | 4.00 | 3.91 | 5.16 | 4.30 | 4.87 | 8.28 | 7.18 |
Average Assets |
— | 860.58 | 1,733.26 | 1,931.49 | 2,120.12 | 1,974.26 | 1,457.65 | 912.44 |
Average Common Equity |
— | 1,206.00 | 1,205.90 | 1,347.70 | 1,490.89 | 1,340.56 | 903.18 | 493.09 |
Columns are period end dates